---
title: "EICHENFIELD LAWRENCE — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2dfd2e4e-4512-540e-ab3f-db0008e0e25c
json: https://whiteintel.dev/api/public/dossier/2dfd2e4e-4512-540e-ab3f-db0008e0e25c
identifier: sec:0001814892
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# EICHENFIELD LAWRENCE

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001814892`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/2dfd2e4e-4512-540e-ab3f-db0008e0e25c  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2dfd2e4e-4512-540e-ab3f-db0008e0e25c  

## Ownership & control

### Holdings / subsidiaries

- **Verrica Pharmaceuticals Inc.** (director) — https://whiteintel.dev/entity/7a229b07-ad6d-5bed-968a-dbb97a6e8c3b
- **Forte Biosciences, Inc.** (director) — https://whiteintel.dev/entity/7a9484a6-90df-50dc-82de-34e2a2b60cfb

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **EICHENFIELD LAWRENCE**. Human view: https://whiteintel.dev/entity/2dfd2e4e-4512-540e-ab3f-db0008e0e25c · Structured JSON: https://whiteintel.dev/api/public/dossier/2dfd2e4e-4512-540e-ab3f-db0008e0e25c._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._